Main content

The Cancer Drugs Fund

The controversial Cancer Drugs Fund for England is being reformed. Will the new model be any better equipped to deal with the pressures of rising cost and demand? Phil Kemp reports.

Over the past five years thousands of patients in England have been given access to new but expensive cancer drugs through a special Cancer Drugs Fund. But critics argue that hundreds of millions have been spent on drugs that offered poor value for money with sometimes limited effects. The Fund is now being reformed but cancer charities have written to the Prime Minister to express deep concern that drugs will now struggle to gain approval. Phil Kemp investigates the record of the Cancer Drugs Fund and asks if the proposed changes will offer better value for money or access for patients.

Reporter: Phil Kemp
Producer: Anna Meisel.

Available now

38 minutes

Last on

Sun 12 Jun 2016 17:00

READ THE PROGRAMME TRANSCRIPT

The controversial Cancer Drugs Fund for England is being reformed. Will the new model be any聽better equipped to deal with the pressures of rising cost and demand? Phil Kemp reports.

Broadcasts

  • Tue 7 Jun 2016 20:00
  • Sun 12 Jun 2016 17:00

Download this programme

Subscribe to this programme or download individual episodes.

Podcast